The Board denied an initial rating in excess of 30 percent for chronic bronchitis and remanded claims for earlier effective dates for TDIU and DEA.
The deciding factor: The Veteran's FEV-1 was 58% predicted post-bronchodilator, which did not meet the criteria for a higher rating under DC 6600.
- Claimed conditions
- Chronic Bronchitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 12, 2025
- Citation
- A25022834
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied an effective date earlier than August 10, 2022, for the grant of a 60 percent rating for sarcoidosis, asthma, chronic bronchitis, and COPD.
- Denied
The Board denied the veteran's claims for increased ratings for sinusitis and chronic allergic rhinitis, and remanded the claim for service connection for chronic bronchitis.
- Denied
The Board denied service connection for asthma, sinusitis, and noncompensable ratings for chronic bronchitis and rhinitis due to insufficient evidence of current disability.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.